Oestradiol decreases rat apolipoprotein AI transcription via promoter site B

Journal of Molecular Endocrinology

Volumn 25, Issue 2, 2000, Pages 207-219

  Taylor, A H ^a   Fox Robichaud, A E ^a   Egan, C ^a   Dionne, J ^a   Lawless, D E ^a   Raymond, J ^a   Romney, J ^a   Wong, N C W ^a  

^a Departments of Medicine and Community Health Sciences   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; ESTRADIOL; ESTROGEN; HIGH DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; DNA TEMPLATE; ESTRADIOL BLOOD LEVEL; GENE DELETION; GENE EXPRESSION; GENE ISOLATION; GENETIC TRANSCRIPTION; HEPATOMA CELL; HYPOTHESIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; REPORTER GENE;

EID: 0033771261     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.0.0250207     Document Type: Article

References (66)

1. Unit 12.1 DNA-protein Interactions
2. Estrogen and coronary heart disease in women
3. High density lipoproteins and coronary heart disease
4. Lipophilic impurities, not phenolsulfonphthalein, account for the estrogenic activity in commercial preparations of phenol red
5. The epidemiology of cardiovascular disease in postmenopausal women
6. Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from the Lipid Research Clinics Program Follow-up Study
7. The estrogen receptor regulates NFκB and AP-1 activity in a cell-specific manner
8. HNF-4 increases activity of the rat apo AI gene
9. Stimulation of prostacyclin biosynthetic activity by estradiol in rat aorta smooth muscle cell in culture
10. Low and high responders - At what levels of serum estradiol do things start to get fuzzy?
11. Thyroid hormone and estrogen interact to regulate behaviour
12. Histology of coronary arteries in newborn infants
13. The vascular protective effects of estrogen
14. Myocardial infarction and severe thromboembolic complications. As seen in an estrogen-dependent transsexual
15. Effect of 17 beta-estradiol on endothelium-dependent responses in the rabbit
16. Atherogenic effects of anabolic steroids on serum lipid levels: A literature review
17. Hormonal regulation of apolipoprotein AI
18. Activation of apolipoprotein A-I gene transcription by the liver-enriched factor HNF-3
19. Estrogen regulation of the apolipoprotein AI gene promoter through transcription cofactor sharing
20. Deleterious effects of low-dose oestrogen therapy on coronary status in patients with prostatic cancer
21. Estrogen inhibits the vascular injury response in estrogen receptor-deficient mice
22. OC-2 a novel mammal member of the ONECUT class of homeodomain transcription factors whose function in liver partially overlaps with that of hepatocyte nuclear factor-6
23. Sex hormones and coronary disease: A review of the clinical studies
24. Mechanistic studies of high-density lipoproteins
25. Involvement of early growth response factor Egr-1 in apolipoprotein A-I gene transcription
26. Serum estradiol levels in male cigarette smokers
27. Binding of type II nuclear receptors and estrogen receptor to full and half-site estrogen response elements in vitro
28. Expression of hepatocyte nuclear factor 6 in rat liver is sex-dependent and regulated by growth hormone
29. Hepatocyte nuclear factor 3/forkhead or 'winged helix' proteins: A family of transcription factors of diverse biologic function
30. Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat
31. Matrix metalloproteinase and matrix metalloproteinase inhibitor expression in endometrial stromal cells during progestin-initiated decidualization and menstruation-related progestin withdrawal
32. Abdominal B (AbdB) Hoxa genes: Regulation in adult uterus by estrogen and progesterone and repression in mullerian duct by the synthetic estrogen diethylstilbestrol (DES)
33. 17β-Estradiol potently suppresses cAMP-induced insulin-like growth factor-1 gene activation in primary rat osteoblast cultures
34. Effect of Premarin on survival of men with myocardial infarction
35. Sex and alcohol
36. Transcriptional regulation of alphafetoprotein expression by dexamethasone in human hepatoma cells
37. A regulatory element that mediates co-operation between a PEA3-AP-1 element and an AP-1 site is required for phorbol ester induction of urokinase enhancer activity in HepG2 hepatoma cells
38. Coronary arteries in fetuses, infants, juveniles and young adults
39. Abnormalities of serum apo AI containing lipoprotein particles in patients with primary bilary cirrhosis
40. Evidence for hyperestrogenemia as the link between diabetes mellitus and myocardial infarction
41. Estrogen activates raf-1 kinase and induces expression of Egr-1 in MCF7 breast cancer cells
42. Differential DNA-binding abilities of estrogen receptor occupied with two classes of antiestrogens: Studies using human estrogen receptor overexpressed in mammalian cells
43. Identification of the thyroid hormone-responsive messenger RNA spot 11 as apolipoprotein-AI messenger RNA and effects of the hormone on the promoter
44. The low incidence of myocardial infarction in hepatic cirrhosis: A statistical artifact?
45. Childhood coronary sclerosis
46. Positive and negative regulatory elements control the steroid-responsive ovalbumin promoter
47. Regulation of hepatic apolipoprotein synthesis in the 17α-ethinyl estradiol-treated rat
48. Lipids, atherosclerosis, and the postmenopausal woman: A clinical perspective
49. Apolipoprotein A-I complexed with phospholipid promotes hepatic lipoprotein and apolipoprotein secretion in the perfused hamster liver
50. An updated review of environmental estrogen and androgen mimics and antagonists
51. In vivo regulation of low-density lipoprotein receptors by estrogen differs at the post-transcriptional level in rat and mouse
52. Regulation of lipoprotein metabolism by estrogen in inbred strains of mice occurs primarily by posttranscriptional mechanisms
53. Regulation of apo A-I gene expression by fibrates
54. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
55. Estrogen replacement and coronary heart disease: Effect of survival in post menopausal women
56. The human ribosomal RNA genes: Structure and organization of the complete repeating unit
57. Glucocorticoid increases rat apolipoprotein A-I promoter activity
58. Identification of functional positive and negative thyroid hormone-responsive elements in the rat apolipoprotein A-I promoter
59. Transcriptional regulation of apolipoprotein A-I gene expression by the nuclear receptor RORα
60. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins
61. Effects of high-dose ethinyl estradiol on serum concentrations and hepatic secretion of the very-low-density lipoprotein, triacylglycerol, cholesterol, and apolipoprotein A-I in the rat
62. Estrogen induces adenosine deaminase gene expression in MCF-7 human breast cancer cells: Role of estrogen receptor-Sp1 interactions
63. Oestradiol up-regulates oestrogen receptor, cyclophilin, and glyceraldehyde phosphate dehydrogenase copy 1 mRNA concentrations in endometrium, but down-regulates them in the liver